These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34650932)

  • 1. Safety of a Novel
    Pownall WR; Imhof D; Trigo NF; Ganal-Vonarburg SC; Plattet P; Monney C; Forterre F; Hemphill A; Oevermann A
    Front Cell Infect Microbiol; 2021; 11():675219. PubMed ID: 34650932
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization with a Multivalent
    Imhof D; Pownall W; Hänggeli KPA; Monney C; Román LR; Ortega-Mora LM; Forterre F; Oevermann A; Hemphill A
    Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36680001
    [No Abstract]   [Full Text] [Related]  

  • 3. A
    Imhof D; Pownall WR; Monney C; Oevermann A; Hemphill A
    Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine-Linked Chemotherapy Approach: Additive Effects of Combining the
    Imhof D; Pownall WR; Schlange C; Monney C; Ortega-Mora LM; Ojo KK; Van Voorhis WC; Oevermann A; Hemphill A
    Front Vet Sci; 2022; 9():901056. PubMed ID: 35832325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
    Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
    Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines.
    Cannas A; Naguleswaran A; Müller N; Eperon S; Gottstein B; Hemphill A
    Parasitology; 2003 Apr; 126(Pt 4):303-12. PubMed ID: 12741509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neospora caninum antigens displaying virus-like particles as a bivalent vaccine candidate against neosporosis.
    Xu J; Hiramatsu R; Suhaimi H; Kato T; Fujimoto A; Tokiwa T; Ike K; Park EY
    Vaccine; 2019 Oct; 37(43):6426-6434. PubMed ID: 31515150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic Neospora caninum strains constitutively expressing the bradyzoite NcSAG4 protein proved to be safe and conferred significant levels of protection against vertical transmission when used as live vaccines in mice.
    Marugán-Hernández V; Ortega-Mora LM; Aguado-Martínez A; Jiménez-Ruíz E; Alvarez-García G
    Vaccine; 2011 Oct; 29(44):7867-74. PubMed ID: 21816191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of recombinant Neospora caninum antigens purified from silkworm larvae for the protection of N. caninum infection in mice.
    Yoshimoto M; Otsuki T; Itagaki K; Kato T; Kohsaka T; Matsumoto Y; Ike K; Park EY
    J Biosci Bioeng; 2015 Dec; 120(6):715-9. PubMed ID: 25935502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of a DIVA-like recombinant vaccine composed by rNcSAG1 and rAtHsp81.2 against vertical transmission in a mouse model of congenital neosporosis.
    Bengoa-Luoni SA; Corigliano MG; Sánchez-López E; Albarracín RM; Legarralde A; Ganuza A; Clemente M; Sander VA
    Acta Trop; 2019 Oct; 198():105094. PubMed ID: 31323195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunisation with Neospora caninum subunits rsNcSAG4 and rsNcGRA1 (NcSAG4 and NcGRA1 epitopes construct) in BALB/c mice: the profile of the immune response and controlling the vertical transmission.
    Fernandes Fidelis C; Silva de Araújo L; Prates-Patarroyo PA; Martins-Kalks KH; Licursi de Oliveira L; Vargas Viloria MI; Tafur-Gómez GA; Patarroyo Salcedo JH
    Parasitol Res; 2023 Dec; 123(1):58. PubMed ID: 38110570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene.
    Nishikawa Y; Xuan X; Nagasawa H; Igarashi I; Fujisaki K; Otsuka H; Mikami T
    Vaccine; 2001 Feb; 19(13-14):1710-6. PubMed ID: 11166895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice.
    Rojo-Montejo S; Collantes-Fernández E; López-Pérez I; Risco-Castillo V; Prenafeta A; Ortega-Mora LM
    Vet Res; 2012 Aug; 43(1):62. PubMed ID: 22913428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, purification and antigenicity of Neospora caninum-antigens using silkworm larvae targeting for subunit vaccines.
    Otsuki T; Dong J; Kato T; Park EY
    Vet Parasitol; 2013 Feb; 192(1-3):284-7. PubMed ID: 23102762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low efficacy of NcGRA7, NcSAG4, NcBSR4 and NcSRS9 formulated in poly-ε-caprolactone against Neospora caninum infection in mice.
    Jiménez-Ruiz E; Alvarez-García G; Aguado-Martínez A; Salman H; Irache JM; Marugán-Hernández V; Ortega-Mora LM
    Vaccine; 2012 Jul; 30(33):4983-92. PubMed ID: 22640942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Neospora caninum serodiagnostic antigens for bovine neosporosis.
    Abdelbaky HH; Nishimura M; Shimoda N; Hiasa J; Fereig RM; Tokimitsu H; Inokuma H; Nishikawa Y
    Parasitol Int; 2020 Apr; 75():102045. PubMed ID: 31881363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with microneme protein NcMIC4 increases mortality in mice inoculated with Neospora caninum.
    Srinivasan S; Mueller J; Suana A; Hemphill A
    J Parasitol; 2007 Oct; 93(5):1046-55. PubMed ID: 18163338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a preventive strategy for neosporosis: challenges and future perspectives for vaccine development against infection with Neospora caninum.
    Nishikawa Y
    J Vet Med Sci; 2017 Aug; 79(8):1374-1380. PubMed ID: 28690279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of Neospora hughesi from Neospora caninum based on their immunodominant surface antigen, SAG1 and SRS2.
    Marsh AE; Howe DK; Wang G; Barr BC; Cannon N; Conrad PA
    Int J Parasitol; 1999 Oct; 29(10):1575-82. PubMed ID: 10608444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of protective activities of Neospora caninum bradyzoite antigens, NcBAG1, NcBSR4, NcMAG1, and NcSAG4, in a mouse model of acute parasitic infection.
    Uchida M; Nagashima K; Akatsuka Y; Murakami T; Ito A; Imai S; Ike K
    Parasitol Res; 2013 Feb; 112(2):655-63. PubMed ID: 23229317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.